LERCANIDIPINE TEVA 20 MG

Држава: Израел

Језик: Енглески

Извор: Ministry of Health

Купи Сада

Активни састојак:

LERCANIDIPINE HYDROCHLORIDE

Доступно од:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

АТЦ код:

C08CA13

Фармацеутски облик:

TABLETS

Састав:

LERCANIDIPINE HYDROCHLORIDE 20 MG

Пут администрације:

PER OS

Тип рецептора:

Required

Произведен од:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Терапеутска област:

LERCANIDIPINE

Терапеутске индикације:

Mild to moderate essential hypertension.

Датум одобрења:

2016-09-30

Информативни летак

                                PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with a
doctor’s prescription only
LERCANIDIPINE TEVA
®
10 MG
TABLETS
The active ingredient and its
quantity:
Each tablet contains:
Lercanidipine hydrochloride 10 mg
LERCANIDIPINE TEVA
®
20 MG
TABLETS
The active ingredient and its
quantity:
Each tablet contains:
Lercanidipine hydrochloride 20 mg
For the list of inactive ingredients,
please see section 6.
READ THIS LEAFLET CAREFULLY IN ITS
ENTIRETY BEFORE USING THE MEDICINE.
This
leaflet
contains
concise
information about the medicine. If
you have further questions, refer to
the doctor or pharmacist.
This medicine has been prescribed
to treat your ailment. Do not pass it
on to others. It may harm them even
if it seems to you that their ailment
is similar.
The medicine is not intended for use
in children under 18 years of age.
1. WHAT
IS
THE
MEDICINE
INTENDED FOR?
For the treatment of mild to moderate
hypertension.
THERAPEUTIC GROUP:
Calcium channel blockers of the
dihydropyridine group.
2. B E F O R E
U S I N G
T H E
MEDICINE
DO NOT USE THE MEDICINE IF:
∙ You are pregnant or breastfeeding,
think you are pregnant, are
planning a pregnancy or do not
use contraceptives.
∙ You are sensitive (allergic) to
the active ingredient or to any
of the other ingredients of the
medicine (see section 6), or to
other medicines from this group,
such as: amlodipine, nicardipine,
felodipine, isradipine, nifedipine
or lacidipine.
∙ You suffer from certain heart
diseases, such as: uncontrolled
heart failure, an obstruction
of blood flow from the heart,
unstable angina (angina at rest
or which gradually increases),
or within one month of a heart
attack.
∙ You suffer from a severe liver or
kidney disease.
∙ You are concomitantly taking:
cyclosporine,
antifungal
medicines, such as ketoconazole
or
itraconazole,
macrolide
antibiotics such as erythromycin
or troleandomycin, antiviral
medicines such as ritonavir.
∙ You consume grapefruits or
grapefruit juice.
                                
                                Прочитајте комплетан документ
                                
                            

Документи на другим језицима

Информативни летак Информативни летак Арапски 30-04-2017
Информативни летак Информативни летак Хебрејски 08-01-2017

Обавештења о претрази у вези са овим производом

Погледајте историју докумената